Shares of ImmuCell Corp. (Nasdaq: ICCC) are indicated to open much higher after the comapny announced that its Mastitis drug ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE